Literature DB >> 2842328

Characterization of the promoter for the alpha 1 (IV) collagen gene. DNA sequences within the first intron enhance transcription.

P D Killen1, P D Burbelo, G R Martin, Y Yamada.   

Abstract

Two overlapping clones spanning 19 kilobase pairs (kb) of the 5' end of the alpha 1 (IV) collagen gene were isolated and found to contain a single exon which encoded the 5'-untranslated sequence and 84 base pairs of the signal peptide. The 5' end of this exon was determined to be the 5' end of the transcript by S1 nuclease protection and primer extension. The nucleotide sequence of 1 kb of the 5'-flanking DNA was extremely G + C-rich (greater than 70%) and contained two GC boxes and a putative cAMP regulatory sequence. The transcriptional regulation of the alpha 1 (IV) gene was studied with chimeric gene constructs utilizing 2.5 kb of the 5'-flanking sequence coupled to the gene for chloramphenicol acetyltransferase. Transfection of this construct into differentiating F9 cells resulted in low chloramphenicol acetyltransferase activity compared to beta-actin or Rous sarcoma virus long terminal repeat promoters, although these cells produce large amounts of collagen IV. Inclusion of a 2.7-kb sequence 2.3 kb downstream from the first exon in either orientation increased the transcription of the chloramphenicol acetyltransferase construct approximately 10-fold in F9 cells, but was not active in NIH 3T3 cells, which synthesize little collagen IV. These results indicate the presence of an enhancer within the first intron, which increases the expression of this gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842328

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Characterization of the promoter for the rat and human link protein gene.

Authors:  C Rhodes; P Savagner; S Line; M Sasaki; M Chirigos; K Doege; Y Yamada
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

2.  A highly conserved intronic sequence is involved in transcriptional regulation of the alpha 1(I) collagen gene.

Authors:  D J Liska; J L Slack; P Bornstein
Journal:  Cell Regul       Date:  1990-05

3.  Bifunctional promoter of type IV collagen COL4A5 and COL4A6 genes regulates the expression of alpha5 and alpha6 chains in a distinct cell-specific fashion.

Authors:  Malin Sund; Yohei Maeshima; Raghu Kalluri
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

4.  Identification and characterization of the promoter for the cytotactin gene.

Authors:  F S Jones; K L Crossin; B A Cunningham; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  CpG methylation of an endogenous retroviral enhancer inhibits transcription factor binding and activity.

Authors:  B T Lamb; K Satyamoorthy; L Li; D Solter; C C Howe
Journal:  Gene Expr       Date:  1991

Review 6.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

7.  Characterization of the human 5-lipoxygenase gene.

Authors:  C D Funk; S Hoshiko; T Matsumoto; O Rdmark; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Alpha 1(IV) and alpha 2(IV) collagen genes are regulated by a bidirectional promoter and a shared enhancer.

Authors:  P D Burbelo; G R Martin; Y Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Intracellular signaling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells.

Authors:  G Wolf; P D Killen; E G Neilson
Journal:  Cell Regul       Date:  1991-03

10.  The human enamel protein gene amelogenin is expressed from both the X and the Y chromosomes.

Authors:  E C Salido; P H Yen; K Koprivnikar; L C Yu; L J Shapiro
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.